Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,906 | 3,296 | 3,819 | 2,132 | 3,816 |
| Marketable Securities | 550 | 8,738 | 13,641 | 21,808 | 25,264 |
| TOTAL | $9,799 | $12,534 | $18,058 | $25,490 | $29,505 |
| Non-Current Assets | |||||
| PPE Net | 38 | 42 | 45 | 49 | 52 |
| Investments And Advances | 0 | 0 | 0 | 0 | 539 |
| Other Non-Current Assets | 65 | 70 | 67 | 63 | 60 |
| TOTAL | $103 | $112 | $112 | $112 | $651 |
| Total Assets | $9,902 | $12,646 | $18,170 | $25,602 | $30,156 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 916 | 2,618 | 1,265 | 1,231 | 549 |
| Accrued Expenses | 2,362 | 2,694 | 3,707 | 3,740 | 2,665 |
| Other current liabilities | 222 | N/A | N/A | N/A | 295 |
| TOTAL | $3,513 | $5,636 | $5,168 | $5,195 | $3,521 |
| Non-Current Liabilities | |||||
| TOTAL | $29 | $32 | $36 | $39 | $42 |
| Total Liabilities | $3,542 | $5,668 | $5,204 | $5,234 | $3,563 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,732 | 22,732 | 22,732 | 22,727 | 22,704 |
| Common Shares | 26 | 23 | 23 | 23 | 23 |
| Retained earnings | -98,438 | -94,562 | -88,159 | -80,295 | -73,565 |
| Other shareholders' equity | -353 | -469 | -587 | -721 | -879 |
| TOTAL | $6,360 | $6,978 | $12,966 | $20,368 | $26,593 |
| Total Liabilities And Equity | $9,902 | $12,646 | $18,170 | $25,602 | $30,156 |